2024-06-012025-05-312025-05-31falseSC770285V1 HEALTH LIMITED2025-08-18falseiso4217:GBPxbrli:pureSC7702852024-05-31SC7702852025-05-31SC7702852024-06-012025-05-31SC7702852023-05-22SC7702852024-05-31SC7702852023-05-232024-05-31SC770285bus:SmallEntities2024-06-012025-05-31SC770285bus:AuditExempt-NoAccountantsReport2024-06-012025-05-31SC770285bus:FullAccounts2024-06-012025-05-31SC770285bus:PrivateLimitedCompanyLtd2024-06-012025-05-31SC770285core:WithinOneYear2025-05-31SC770285core:AfterOneYear2025-05-31SC770285core:WithinOneYear2024-05-31SC770285core:AfterOneYear2024-05-31SC770285core:ShareCapital2025-05-31SC770285core:SharePremium2025-05-31SC770285core:RevaluationReserve2025-05-31SC770285core:OtherReservesSubtotal2025-05-31SC770285core:RetainedEarningsAccumulatedLosses2025-05-31SC770285core:ShareCapital2024-05-31SC770285core:SharePremium2024-05-31SC770285core:RevaluationReserve2024-05-31SC770285core:OtherReservesSubtotal2024-05-31SC770285core:RetainedEarningsAccumulatedLosses2024-05-31SC770285core:LandBuildings2025-05-31SC770285core:PlantMachinery2025-05-31SC770285core:Vehicles2025-05-31SC770285core:FurnitureFittings2025-05-31SC770285core:OfficeEquipment2025-05-31SC770285core:NetGoodwill2025-05-31SC770285core:IntangibleAssetsOtherThanGoodwill2025-05-31SC770285core:ListedExchangeTraded2025-05-31SC770285core:UnlistedNon-exchangeTraded2025-05-31SC770285core:LandBuildings2024-05-31SC770285core:PlantMachinery2024-05-31SC770285core:Vehicles2024-05-31SC770285core:FurnitureFittings2024-05-31SC770285core:OfficeEquipment2024-05-31SC770285core:NetGoodwill2024-05-31SC770285core:IntangibleAssetsOtherThanGoodwill2024-05-31SC770285core:ListedExchangeTraded2024-05-31SC770285core:UnlistedNon-exchangeTraded2024-05-31SC770285core:LandBuildings2024-06-012025-05-31SC770285core:PlantMachinery2024-06-012025-05-31SC770285core:Vehicles2024-06-012025-05-31SC770285core:FurnitureFittings2024-06-012025-05-31SC770285core:OfficeEquipment2024-06-012025-05-31SC770285core:NetGoodwill2024-06-012025-05-31SC770285core:IntangibleAssetsOtherThanGoodwill2024-06-012025-05-31SC770285core:ListedExchangeTraded2024-06-012025-05-31SC770285core:UnlistedNon-exchangeTraded2024-06-012025-05-31SC770285core:MoreThanFiveYears2024-06-012025-05-31SC770285core:Non-currentFinancialInstruments2025-05-31SC770285core:Non-currentFinancialInstruments2024-05-31SC770285dpl:CostSales2024-06-012025-05-31SC770285dpl:DistributionCosts2024-06-012025-05-31SC770285core:LandBuildings2024-06-012025-05-31SC770285core:PlantMachinery2024-06-012025-05-31SC770285core:Vehicles2024-06-012025-05-31SC770285core:FurnitureFittings2024-06-012025-05-31SC770285core:OfficeEquipment2024-06-012025-05-31SC770285dpl:AdministrativeExpenses2024-06-012025-05-31SC770285core:NetGoodwill2024-06-012025-05-31SC770285core:IntangibleAssetsOtherThanGoodwill2024-06-012025-05-31SC770285dpl:GroupUndertakings2024-06-012025-05-31SC770285dpl:ParticipatingInterests2024-06-012025-05-31SC770285dpl:GroupUndertakingscore:ListedExchangeTraded2024-06-012025-05-31SC770285core:ListedExchangeTraded2024-06-012025-05-31SC770285dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-06-012025-05-31SC770285core:UnlistedNon-exchangeTraded2024-06-012025-05-31SC770285dpl:CostSales2023-05-232024-05-31SC770285dpl:DistributionCosts2023-05-232024-05-31SC770285core:LandBuildings2023-05-232024-05-31SC770285core:PlantMachinery2023-05-232024-05-31SC770285core:Vehicles2023-05-232024-05-31SC770285core:FurnitureFittings2023-05-232024-05-31SC770285core:OfficeEquipment2023-05-232024-05-31SC770285dpl:AdministrativeExpenses2023-05-232024-05-31SC770285core:NetGoodwill2023-05-232024-05-31SC770285core:IntangibleAssetsOtherThanGoodwill2023-05-232024-05-31SC770285dpl:GroupUndertakings2023-05-232024-05-31SC770285dpl:ParticipatingInterests2023-05-232024-05-31SC770285dpl:GroupUndertakingscore:ListedExchangeTraded2023-05-232024-05-31SC770285core:ListedExchangeTraded2023-05-232024-05-31SC770285dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-05-232024-05-31SC770285core:UnlistedNon-exchangeTraded2023-05-232024-05-31SC770285core:NetGoodwill2025-05-31SC770285core:IntangibleAssetsOtherThanGoodwill2025-05-31SC770285core:LandBuildings2025-05-31SC770285core:PlantMachinery2025-05-31SC770285core:Vehicles2025-05-31SC770285core:FurnitureFittings2025-05-31SC770285core:OfficeEquipment2025-05-31SC770285core:AfterOneYear2025-05-31SC770285core:WithinOneYear2025-05-31SC770285core:ListedExchangeTraded2025-05-31SC770285core:UnlistedNon-exchangeTraded2025-05-31SC770285core:ShareCapital2025-05-31SC770285core:SharePremium2025-05-31SC770285core:RevaluationReserve2025-05-31SC770285core:OtherReservesSubtotal2025-05-31SC770285core:RetainedEarningsAccumulatedLosses2025-05-31SC770285core:NetGoodwill2024-05-31SC770285core:IntangibleAssetsOtherThanGoodwill2024-05-31SC770285core:LandBuildings2024-05-31SC770285core:PlantMachinery2024-05-31SC770285core:Vehicles2024-05-31SC770285core:FurnitureFittings2024-05-31SC770285core:OfficeEquipment2024-05-31SC770285core:AfterOneYear2024-05-31SC770285core:WithinOneYear2024-05-31SC770285core:ListedExchangeTraded2024-05-31SC770285core:UnlistedNon-exchangeTraded2024-05-31SC770285core:ShareCapital2024-05-31SC770285core:SharePremium2024-05-31SC770285core:RevaluationReserve2024-05-31SC770285core:OtherReservesSubtotal2024-05-31SC770285core:RetainedEarningsAccumulatedLosses2024-05-31SC770285core:NetGoodwill2023-05-22SC770285core:IntangibleAssetsOtherThanGoodwill2023-05-22SC770285core:LandBuildings2023-05-22SC770285core:PlantMachinery2023-05-22SC770285core:Vehicles2023-05-22SC770285core:FurnitureFittings2023-05-22SC770285core:OfficeEquipment2023-05-22SC770285core:AfterOneYear2023-05-22SC770285core:WithinOneYear2023-05-22SC770285core:ListedExchangeTraded2023-05-22SC770285core:UnlistedNon-exchangeTraded2023-05-22SC770285core:ShareCapital2023-05-22SC770285core:SharePremium2023-05-22SC770285core:RevaluationReserve2023-05-22SC770285core:OtherReservesSubtotal2023-05-22SC770285core:RetainedEarningsAccumulatedLosses2023-05-22SC770285core:AfterOneYear2024-06-012025-05-31SC770285core:WithinOneYear2024-06-012025-05-31SC770285core:Non-currentFinancialInstrumentscore:CostValuation2024-06-012025-05-31SC770285core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-06-012025-05-31SC770285core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-06-012025-05-31SC770285core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-06-012025-05-31SC770285core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-06-012025-05-31SC770285core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-06-012025-05-31SC770285core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-06-012025-05-31SC770285core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-06-012025-05-31SC770285core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-06-012025-05-31SC770285core:Non-currentFinancialInstrumentscore:CostValuation2025-05-31SC770285core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-05-31SC770285core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-05-31SC770285core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-05-31SC770285core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-05-31SC770285core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-05-31SC770285core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-05-31SC770285core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-05-31SC770285core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-05-31SC770285core:Non-currentFinancialInstrumentscore:CostValuation2024-05-31SC770285core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-05-31SC770285core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-05-31SC770285core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-05-31SC770285core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-05-31SC770285core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-05-31SC770285core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-05-31SC770285core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-05-31SC770285core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-05-31SC770285bus:Director12024-06-012025-05-31

V1 HEALTH LIMITED

Registered Number
SC770285
(Scotland)

Unaudited Financial Statements for the Year ended
31 May 2025

V1 HEALTH LIMITED
Company Information
for the year from 1 June 2024 to 31 May 2025

Director

WOLL, Raymond David

Registered Address

17/3 Rothesay Terrace
Edinburgh
EH3 7RY

Registered Number

SC770285 (Scotland)
V1 HEALTH LIMITED
Balance Sheet as at
31 May 2025

Notes

2025

2024

£

£

£

£

Current assets
Debtors316,08116,081
Cash at bank and on hand9,86912,912
25,95028,993
Creditors amounts falling due within one year4(77,369)(26,067)
Net current assets (liabilities)(51,419)2,926
Total assets less current liabilities(51,419)2,926
Creditors amounts falling due after one year5(13,094)(212)
Net assets(64,513)2,714
Capital and reserves
Called up share capital100100
Profit and loss account(64,613)2,614
Shareholders' funds(64,513)2,714
The financial statements were approved and authorised for issue by the Director on 18 August 2025, and are signed on its behalf by:
WOLL, Raymond David
Director
Registered Company No. SC770285
V1 HEALTH LIMITED
Notes to the Financial Statements
for the year ended 31 May 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
2.Average number of employees

20252024
Average number of employees during the year11
3.Debtors: amounts due after one year

2025

2024

££
Amounts owed by group undertakings 16,08116,081
Total16,08116,081
4.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables2,095-
Taxation and social security72,87423,667
Accrued liabilities and deferred income2,4002,400
Total77,36926,067
5.Creditors: amounts due after one year

2025

2024

££
Amounts owed to related parties13,094212
Total13,094212